Literature DB >> 22715211

Evolving epidemiology of hepatitis C virus in the United States.

R Monina Klevens1, Dale J Hu, Ruth Jiles, Scott D Holmberg.   

Abstract

The impact of hepatitis C virus (HCV) infection on health and medical care in the United States is a major problem for infectious disease physicians. Although the incidence of HCV infection has declined markedly in the past 2 decades, chronic infection in 3 million or more residents now accounts for more disease and death in the United States than does human immunodeficiency virus (HIV)/AIDS. Current trends in the epidemiology of HCV infection include an apparent increase in young, often suburban heroin injection drug users who initiate use with oral prescription opioid drugs; infections in nonhospital healthcare (clinic) settings; and sexual transmission among HIV-infected persons. Infectious disease physicians will increasingly have the responsibility of diagnosing and treating HCV patients. An understanding of how these patients were infected is important for determining whom to screen and treat.

Entities:  

Mesh:

Year:  2012        PMID: 22715211      PMCID: PMC5774980          DOI: 10.1093/cid/cis393

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  50 in total

1.  Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.

Authors:  Michael P Busch; Simone A Glynn; David J Wright; Dale Hirschkorn; Megan E Laycock; Joan McAuley; Yongling Tu; Cristina Giachetti; James Gallarda; John Heitman; Steven H Kleinman
Journal:  Transfusion       Date:  2005-12       Impact factor: 3.157

Review 2.  Manifestations of chronic hepatitis C virus infection beyond the liver.

Authors:  Ira M Jacobson; Patrice Cacoub; Luigino Dal Maso; Stephen A Harrison; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2010-09-24       Impact factor: 11.382

Review 3.  Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough.

Authors:  Kimberly Page-Shafer; Judith A Hahn; Paula J Lum
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

4.  National surveillance of dialysis-associated diseases in the United States, 2002.

Authors:  Lyn Finelli; Jeremy T Miller; Jerome I Tokars; Miriam J Alter; Matthew J Arduino
Journal:  Semin Dial       Date:  2005 Jan-Feb       Impact factor: 3.455

Review 5.  Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update.

Authors:  Bryce D Smith; Cynthia Jorgensen; Jon E Zibbell; Geoff A Beckett
Journal:  Clin Infect Dis       Date:  2012-07       Impact factor: 9.079

6.  Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men--New York City, 2005-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-07-22       Impact factor: 17.586

7.  Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).

Authors:  Toni Frederick; Pamela Burian; Norah Terrault; Mardge Cohen; Michael Augenbraun; Mary Young; Eric Seaberg; Jessica Justman; Alexandra M Levine; Wendy J Mack; Andrea Kovacs
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

8.  Hepatitis C virus transmission at an outpatient hemodialysis unit--New York, 2001-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-03-06       Impact factor: 17.586

9.  Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.

Authors:  Joseph J Amon; Richard S Garfein; Linda Ahdieh-Grant; Gregory L Armstrong; Lawrence J Ouellet; Mary H Latka; David Vlahov; Steffanie A Strathdee; Sharon M Hudson; Peter Kerndt; Don Des Jarlais; Ian T Williams
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Problematic use of prescription-type opioids prior to heroin use among young heroin injectors.

Authors:  Robin A Pollini; Caleb J Banta-Green; Jazmine Cuevas-Mota; Mitcheal Metzner; Eyasu Teshale; Richard S Garfein
Journal:  Subst Abuse Rehabil       Date:  2011-10
View more
  85 in total

1.  Ledipasvir/Sofosbuvir.

Authors:  Dennis J Cada; Danial E Baker; Ross Jason Bindler
Journal:  Hosp Pharm       Date:  2015-03

2.  The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care.

Authors:  Andrew D Schreiner; John Bian; Jingwen Zhang; Z Merle Haulsee; Justin Marsden; Valerie Durkalski-Mauldin; Patrick D Mauldin; William P Moran; Don C Rockey
Journal:  Am J Med       Date:  2019-07-29       Impact factor: 4.965

Review 3.  Estimating the true prevalence of hepatitis C in rhode island.

Authors:  Elizabeth N Kinnard; Lynn E Taylor; Omar Galárraga; Brandon D L Marshall
Journal:  R I Med J (2013)       Date:  2014-07-01

4.  National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.

Authors:  Christopher M Jones; Melinda Campopiano; Grant Baldwin; Elinore McCance-Katz
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

Review 5.  Novel therapies for hepatitis C - one pill fits all?

Authors:  Michael P Manns; Thomas von Hahn
Journal:  Nat Rev Drug Discov       Date:  2013-06-28       Impact factor: 84.694

6.  Chronic hepatitis C virus (HCV) burden in Rhode Island: modelling treatment scale-up and elimination.

Authors:  A I Soipe; H Razavi; D Razavi-Shearer; O Galárraga; L E Taylor; B D L Marshall
Journal:  Epidemiol Infect       Date:  2016-08-05       Impact factor: 2.451

Review 7.  Hepatitis C virus: an overview for dental health care providers.

Authors:  R Monina Klevens; Anne C Moorman
Journal:  J Am Dent Assoc       Date:  2013-12       Impact factor: 3.634

Review 8.  Estimating acute viral hepatitis infections from nationally reported cases.

Authors:  R Monina Klevens; Stephen Liu; Henry Roberts; Ruth B Jiles; Scott D Holmberg
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

9.  Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009.

Authors:  Alia A Al-Tayyib; Hanne Thiede; Richard D Burt; Stephen Koester
Journal:  Prev Sci       Date:  2015-02

10.  Syringe Service Program Utilization, Barriers, and Preferences for Design in Rural Appalachia: Differences between Men and Women Who Inject Drugs.

Authors:  Kathryn E Lancaster; Hannah L F Cooper; Christopher R Browning; Carlos D Malvestutto; John F P Bridges; April M Young
Journal:  Subst Use Misuse       Date:  2020-08-04       Impact factor: 2.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.